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Dear SA Heart® Members
In November last year, the SA Heart® Board met for a 
2-day strategy session to discuss our structure, vision, 
mission, as well as a new way forward for our association. 
This meeting was ably facilitated by Mr Chandu Kashiram, 
who is a self-employed business consultant, with particular 
expertise in risk management, compliance, ethics, govern-
ance, as well as internal control and financial management. 
We are extremely fortunate and grateful that Chandu has 
volunteered these services to SA Heart®. 
SA Heart®’s vision is to Advance Cardiovascular Care for 
all living in South Africa, and as the scientific leaders in this 
country, we have identified 4 main pillars that underpin our 
goals: science, education, membership and policy. If we 
align all our efforts to these key values, we will achieve our 
mission, which is to champion equitable, sustainable health-
care, leading and innovating in the cardiovascular sciences, 
educating professionals, our members and the community; 
and, importantly, to influence healthcare policy. Our direc-
tion must involve the entire SA Heart® family, if we are to 
remain the key opinion leaders and the go-to organisation 
in cardiovascular health. We sincerely hope that you will 
enthusiastically follow us on this path. 
We are now in the process of aligning our Memorandum of 
Incorporation into a new model. Our vision, mission and 
strategic pillars, combined with a code of conduct the 
Board has developed, will firstly influence direction of the 
Board, the work in our standing committees, our regional 
branches and special interest groups (SIGs). 
Our 4 standing committees have often indicated that their 
mandate is not clear. We have therefore drawn up new 
terms of reference for them to function under. It is also 
imperative that all SIGs have representation within these 
committees.
It has been decided to amalgamate the Education and Full-
time Salaried Committees, as they are greatly involved in 




activities. In the future, a full-time business unit will have to 
be funded by a monthly fee to all those who require the 
PPC service. 
receNt PPc issues
SAMA mistakenly placed a rule that code 1252 (coronary 
angiography) cannot be charged when an angioplasty is 
performed! This was picked up by 2 of the funders and 
potentially would result in huge consequences for those in 
private practice. Fortunately, SAMA has agreed to imme-
diately correct this mistake. They have assured the PPC 
that they will constructively engage with us in future. 
Dr Vorster met with SAMA last week in this regard. 
We recently have resolved a number of other issues 
with various funders. I ask those who request PPC assis-
tance to be patient with the committee – they are not 
full-time employees to perform these duties. 
We are planning to form a new congress committee to 
streamline organisation and the scientific programme plan-
ning. We want to avoid “re-inventing the wheel” every 
year with a committee that has never before organised a 
national congress. The historic rotation through the 
branches will be incorporated by asking the respective 
branches to appoint 2 representatives to serve in a parti-
cular year. As has always been customary, the congress 
committee will have representation from all interested 
SIGs. While experienced convenors will form the initial 
core of the committee, younger members will be recruited. 
We need emerging, energetic and youthful leaders on 
board with us. 
SA Heart® recently partnered with the ESC for angina 
awareness month. The project was funded by Servier 
Laboratories. We thank all of those who were involved in 
media interviews to educate and inform the public about 
the significance of angina. We have been informed that the 
campaign achieved a significant reach and perhaps has even 
saved some lives.  
Please follow SA Heart® on social media (Facebook and 
Twitter) with our extremely vibrant programme. In this 
regard I thank Professor Zühlke and Carrine Visagie. 
Facebook remains our strongest social media platform and 
similar aspects of work. This new committee will be 
responsible for educational programmes for our members 
(together with SIG programmes and regional CPD (Con-
tinuing Professional Development) accredited meetings). 
The Ethics and Guidelines Committee will peruse new 
editions of European Society of Cardiology (ESC) guide-
lines, consider whether they would need a local position 
statement/comment, and consider commentaries on the 
ethics of current important cardiovascular-related issues in 
the news. The committee’s mandate states that personal 
ethics of practitioners are not the gambit of this com-
mittee. I, however, believe that we should play such a role. 
A recent complaint (from a patient with regard to a 
particular cardiology practice) was successfully resolved 
by Dr Osrin, before this could have been escalated to 
the Health Professions Council. We therefore believe that 
such intervention may well avoid further difficult and legal 
consequences. 
The South African Society of Cardiovascular Intervention 
(SASCI) Private Practice Committee (PPC) will continue to 
represent SA Heart® without the need for an additional 
separate similar committee. The Board has thanked and 
expressed our gratitude to SASCI. Dr JP Theron has 
resigned as the chairman of the PPC. We hugely thank 
JP for his work in the past. Dr Jean Vorster has now been 
appointed chairman as such. The PPC will also now have 
wider representation from all of the SIGs. The main 
objective for this year is a CPT (Current Procedural 
Terminology) cross-walk to determine what the billing/
coding will look like under CPT as opposed to the usual 
SAMA (South African Medical Association) coding. Once 
the cross-walk has been completed, we will engage with 
the funders for a cost-analysis thereof. Karen van der 
Westhuizen (independent clinical coding consultant and 
auditor) has been consulted. CPT takes  the ambiguity out 
of the whole coding process and disincentivises practi-
tioners for over-servicing; it rather rewards for appropriate 
management. The ultimate aim in the next 2 - 3 years will 
be to develop a full-time business unit with permanent 
staff/experts to take care of our private practice members’ 
issues, and to engage with funders when problems arise. 
It is important that SASCI is presently funding the PPC 
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posts have reached 89 250 individuals, up from 20 000 
since the beginning of this year. The following is interest-
ingly predominantly female (72%), with the greatest per-
centage between the ages of 25 - 34 years. The community 
is very responsive in terms of sharing posts, as well as 
commenting and responding to them. We currently have 
more followers on Facebook than the Heart & Stroke 
Foundation South Africa. Twitter growth remains a challenge 
(it’s harder to advertise effectively on this platform). Please 
help us to grow our Twitter community by sharing our 
posts. Please would you also forward any local and relevant 
content for inclusion on these platforms.
This year is the 20th anniversary of SA Heart®. In cele-



















to highlight our work, the achievements of our members 
and our plans for the future. We look forward to sharing 
these and other events with you in the next months. 
Please don’t hesitate to contact me with any 
suggestions. I also invite you to co-opt yourselves 
onto the various committees. We need more 







Please also consult the sA heart® online calendar at www.saheart.org/events/eventcalendar for constant updates 
as well as a number of iscAP workshops and sAsci/sA Visiting Professor evening lectures around the country.
PoPuLAr coNGresses for 2019/2020
 coNGress dAte citY couNtrY
AmerIcAN SOcIety Of ecHOcArDIOgrAPHy 21 - 25 June 2019 Portland United States  
cONfereNce   of America
https://www.emedevents.com/c/medical-conferences-2019/american-society-of-echocardiography-ase-30th-annual-scientific-sessions
cSI frANkfurt 2019 26 - 29 June 2019 Frankfurt   Germany
https://www.csi-congress.org 
NeW HOrIzONS IN ecHOcArDIOgrAPHy 11 - 14 July 2019 Johannesburg  South Africa
www.newhorizonsinechocardiography.co.za  
SOcIety Of cArDIOtHOrAcIc SurgeONS Of 18 - 21 July 2019 Durban   South Africa
SOutH AfrIcA meetINg
Contact Desiree Naicker at desiree@confco.co.za
eSc cONgreSS 2019/WOrlD cONgreSS Of 31 August - 04 September 2019 Paris  France
cArDIOlOgy
https://www.escardio.org/Congresses-&-Events/ESC-Congress
tct 2019 25 - 29 September 2019 San Francisco  United States
   of America
http://tct-congress.org  
PAscAr/20th ANNuAL sA heArt® 31 october -  sandton  south Africa
coNGress/ AfricAPcr 2019 3 November 2019
http://www.saheart.org/congress2019
AHA 2019 ScIeNtIfIc SeSSIONS 16 - 18 November 2019 Philadelphia  United States
   of America
https://professional.heart.org/professional/index.jsp
Pcr lONDON VAlVeS 17 - 19 November 2019 London  United Kingdom
https://www.escardio.org/Congresses-&-Events/EuroEcho 
cSI AfrIcA 2019 29 - 30 November 2019 Dar es Salaam  Tanzania
www.csi-congress.org/csi-africa.php
eurOecHO 2019 04 - 07 December 2019 Vienna  Austria
https://www.escardio.org/Congresses-&-Events/PCR-London-Valves 
ScAI 2019 fAll fellOWS cOurSeS 07 - 10 December 2019 Las Vegas  United States
   of America
https://www.scai.org




Prof Sliwa acknowledges that the cardiovascular challenges 
are diverse in the different regions of the globe. She points 
to the scenario, for example, in many sub-Saharan countries 
where less than 5% of the population is older than 65.
“Therefore, the goal can’t be to only reduce premature 
cardiovascular disease mortality but to address the better 
management of hypertension and to improve care of 
patients suffering from rheumatic heart disease or heart 
failure due to an idiopathic cardiomyopathy,” she said.
 “I know that each country and region has its strengths and 
weaknesses, and that there are lessons we can learn from 
each other, irrespective of the level of health development.
“During our last congress in Dubai, I spent a lot of 
time listening and talking to as many WHF members and 
partners as I could to ensure that we can understand 
better what they need and how we can help.  Even small 
changes in skill transfer or legislation, for example, can have 
a huge impact.”
Her main areas of clinical and pathophysiological research 
are around heart failure, CVD related to poverty such as 
Rheumatic Heart Disease (RHD) and peripartum cardiac 
conditions, and she stresses that these topics will continue 
to have a “special place” in her heart alongside her overall 
key goals.
A s Professor Karen Sliwa took over as the first female President of the World Heart Federation, she summarises her hopes, goals and aspirations. 
In becoming the first female President of the World Heart 
Federation (WHF) in its 40-year history, Professor Karen 
Sliwa has outlined her focussed overall goal for her 2-year 
tenure: “Equity and heart health for everyone.”
Within that, she continued: “My hopes and aspirations for 
the WHF are to ensure that as many human beings as 
possible, regardless of their country, region, origin, race, 
gender, age, education and revenues, are entitled to the 
best cardiovascular health and well-being.”
Taking over as President from January 2019, Prof Sliwa has 
taken a year of sabbatical leave from her current position 
as Director of the Hatter Institute for Cardiovascular 
Research in Africa at the University of Cape Town to focus 
on her new role. However, her research projects, some 
clinical work and supervision of post-doctoral students 
will continue.
She believes the role of the WHF, with a large board of 
active and high-profile members, is very well positioned to 
tackle all aspects of cardiovascular disease (CVD): “In a 
connected and changing world, where collaboration is 
increasingly seen to be the norm, the role of the WHF is 
unique in dealing with the prevention and management 
of cardiovascular disease because we are the only global 
representative body for the entire cardiovascular com-
munity (including the national and continental cardiology 
scientific societies and foundations).”
WHF represents more than 200 organisations, each with 
cardiologists, specialist physicians, cardiothoracic surgeons, 
paediatric cardiologists, basic scientists, nurses and com-
munity workers as members.
“In this sense, we are the only voice dealing with all aspects 
of cardiovascular diseases at the global level,” she added. 
“We do this through our official relations with the World 
Health Organisation and we also voice our vision and 
concerns with other bodies such as the United Nations, the 
World Bank and relevant stakeholders.”
first femALe PresideNt of the worLd heArt federAtioN
Continued on page 154
Professor faustos Pinto, Professor karen Sliwa and 





Prof Sliwa has identified several specific areas as being 
equally important to fulfil the mission of WHF. She is par-
ticularly keen to strengthen the organisation’s leadership 
role in global advocacy and WHF has just adopted an 
Advocacy strategy which will continue to rally members 
and partners around existing agendas such as the SDGs 
(Sustainable Development Goals) as well as more cardio-
vascular-specific topics, including RHD and Chagas disease.
“I am also particularly keen to ensure that WHF continues 
to be financially sustainable, and put into place measurement 
and evaluation frameworks,” she added.
Her tenure comes at a time of continuing challenges facing 
the prevention and treatment of CVD – more than a billion 
people have hypertension with 47% unaware of their con-
dition and only one in seven having it under control.
“This is unacceptable, as solutions do exist,” said Prof Sliwa. 
“Investing in interventions to tackle non-communicable 
diseases (NCDs) is a matter of health justice, affecting the 
most vulnerable among us. For many patients and their 
families in low- to middle-income countries, having a heart 
attack or heart failure has a catastrophic impact on the 
household.”
She points to data showing that often more than 25% of 
the household income is spent on medication and how the 
recent report “Saving Lives, Spending Less” demonstrates 
real return on investment for governments. “For every 
US$1 per person per year spent on the WHO Best Buys, 
there is a yield of US$7, and a priceless return in improved 
health and well-being,” she explained.
Prof Sliwa recognises the need to reflect the WHO 
approach in calling for a “whole of government, whole of 
society”, approach to health policies. Rather than just 
interact with health ministries, the health and scientific 
community should seek relationships with other govern-
first femALe PresideNt continued




ment departments such as finance and trade ministries and 
the environmental departments that are “responsible for 
cleaning up the air we breathe.”
“In order to meet the past and future challenges, we will 
prioritise economic arguments alongside the commitment 
to reduce disease and death,” she vowed. “We will also 
continue to ensure that the most successful WHF advocacy 
continues to be as successful as it was in the past, specifically 
in areas where WHF added unique value such as RHD.”
RHD is a topic Prof Sliwa is particularly interested in, having 
been involved in important trials in Soweto, South Africa, 
and elsewhere in Africa and having worked extensively in 
maternal cardiac health. 
With the passing of a WHO Resolution on RF (Rheumatic 
Fever) and RHD in May 2018, she believes this heralds a 
new era for RHD as the Resolution focuses attention on 
RHD and commits the WHO, member states and the 
global community to work concretely on eradicating the 
disease. In response, WHF established a taskforce – which 
Prof Sliwa leads – to work towards implementing the 
Resolution and aiming to take a comprehensive look at 
tackling all aspects of RHD.  The aim of this task force is to 
encourage all the clinicians and researchers who have been 
working on tackling RHD on numerous levels to join forces 
and to work well together. 
That includes ensuring reliable access to BPG (Benzathine 
Penicillin G) – a form of penicillin which is currently the 
only effective antibiotic available to prevent the develop-
ment of RHD – and working towards increasing cardiac 
surgery capacity to treat established RHD cases. With a 
global shortage of the drug, as well as issues surrounding its 
administration, WHF is working with WHO and pharma-
ceutical manufacturers to try to ensure BPG availability and 
identify and solve issues related to its use on the ground. 
The WHF is also closely working with organisations such as 
RhEACH, led by Prof Liesl Zühlke and Prof Jonathan 
Carapetis. 
She said: “Our other focus this year is on improving access 
to surgical treatments for those whose disease can no 
longer be treated with medication alone.” That sees WHF 
partnering the newly-established Cardiac Surgery Inter-
society Alliance (CSIA), an umbrella organisation under the 
leadership of Prof Peter Zilla whose goal is to address the 
gap in cardiac surgical services for RHD, to work on pilot 
projects for the development of local capacity-building in 
low-income countries.
A strong advocate of the WHF Salim Yusuf Emerging 
Leaders programme, Prof Sliwa sees it as “a great oppor-
tunity for empowering the next generation of leaders to 
shape the future of cardiovascular health.”
Each year, WHF invites 25 outstanding individuals to meet, 
share experience and participate in ground-breaking 
research, with the programme for this year focussing on the 
implementation of the WHF Roadmap on Heart Failure.
She also acknowledges the importance of supporting 
smaller organisations that are seeking assistance, input and 
engagement from WHF and spending time to nurture 
these organisations and provide them with effective 
leadership.
“I represent Africa and low-income countries and therefore 
this will be a key focus during my presidency,” she added.
RHD is a topic 










Major points in her tenure will be the United Nations High 
Level Meeting on Universal Health Coverage and the 2019 
Climate Summit, and she also recognises the significance of 
her being the first female WHF President.
“I have often been the first female holding a certain posi-
tion in the discipline of cardiology that historically trained 
much fewer women than men,” she said. One position was 
the first female SA Heart® president. “I think it is rather 
regretful that it took four decades that the president of the 
WHF happened to be of female gender.
“However, I constantly encourage women to put their 
name forward to serve on boards and to make themselves 
available to lead organisations. I am glad to lead a gender-
balanced WHF board. There is clear evidence from the 
business world that gender-balanced boards are strategically 
more successful … and I think that the meetings are more 
lively!”
whf ANd esc euroPeAN coNGress 
In 2019 the WHF will join forces with the European Society 
of Cardiology in holding a joint congress in Paris on 
31 August - 4 September 2019. The theme of the congress 
first femALe PresideNt continued
Professor Barbara casadei and Professor  
karen Sliwa.
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worLd heArt  www.world-heart-federation.org
is “Global Heart”. Prof Sliwa invites SA Heart® members 
to participate in the interactive congress as there will be 




Inaugural PrOteA Workshop programme.
 ■ mission: conducting innovative, patient-centred and 
accountable research with the focus on African areas 
of need. 
two key projects are reAcH and PrOteA. 
reAch:  to stoP rheumAtic  
heArt diseAse 
ReACH was founded in 2014 by Prof Jonathan Carapetis 
and Prof Zühlke and is a scientific and technical initiative 
to achieve RHD control. ReACH works across 3 strategic 
areas: People – supporting those living with and affected by 
RHD, Policy – ensuring ARF(Acute Rheumatic Fever)/RHD 
are national health priorities in endemic countries, and Pro-
grammes – providing technical assistance on ARF/RHD 
prevention and control. 
ProteA:  the ProteA studY 
Partnerships for Congenital Heart Disease in Africa (The 
PROTEA Study) aims to address gaps in evidence in con-
genital heart disease (CHD) epidemiology by establishing 
a comprehensive phenotype and genotype registry, 
developing a biobank for DNA extraction and genetic 
analysis, and utilising computational fluid dynamics to 
potentially develop new treatment modalities for CHD. 
A key component of this study is capacity-building, teach-
ing and training, and expanding into other sites in Africa. 
These 2 interests were merged in this workshop: bring- 
ing together colleagues from South Africa and around the 
world to focus on novel research ideas to impact and 
change the lives of those living with RHD and then provid-
ing some feedback and further training into echo-
cardiography as we demonstrate how research can impact 
clinical practice. 
reseArch methods
A data management and research methods workshop for 
programme managers involved in Cape Town studies which 
will be extending to Namibia, Zambia and Botswana was 
coordinated by A Prof Mark Engel. The workshop touched 
on many essential elements in research, ranging from study 
design and literature review to data management and 
quality control. Workshop attendees enjoyed interactive 
and engaging sessions designed to mimic real life scenarios. 
In particular, role-playing the consent process gave partici-
The 13 - 16 March 2019 marked the Inaugural PROTEA 
(Partnerships for Children with Heart Disease in Africa) 
Workshop, hosted by the Children’s Heart Disease 
Research Unit (CHDRU) directed by Associate Professor 
Liesl Zühlke in conjunction with the Western Cape Paedi-
atric Cardiology Service. It was opened by the Vice-Chan-
cellor of the University of Cape Town, Prof Mamokgethi 
Phakeng. A first in Africa, this workshop combined four 
events: a research methods workshop, a basic echo-
cardiography workshop, followed by 2 days of advanced 
echo, as well as a Rheumatic Heart Disease (RHD) research 
think-tank.
the cHDru was established in 2015 by A/Prof zühlke 
with the goals to: 
 ■ Conduct, promote and support children’s heart 
research on the African continent
 ■ Facilitate Implementation Science
 ■ Provide postgraduate supervision and training in 
children’s heart research.
cHDru’s Vision and mission are: 
 ■ Vision: integrating research and clinical practice to 
improve the lives of all with congenital and paediatric 
heart disease
the iNAuGurAL ProteA worKshoP                               




pants the opportunity to witness and then discuss some of 
the more common challenges which often arise. 
BAsic echo
The basic echo workshop included hands-on sessions and a 
thorough introduction to basic paediatric echocardiography. 
Broadly, the workshop covered the evaluation of both 
simple and common CHDs as well as advanced techniques 
in acquired heart disease. Hands-on sessions gave parti-
cipants the opportunity to put their new-found knowledge 
into practice. This was the first echo workshop dedicated to 
paediatric echo to be held in South Africa and had great 
interest from all.
AdVANced echo
Following on from the basic echo workshop, the advanced 
echo workshop included 2 days of didactic lectures, practical 
sessions and a hilarious and very useful echo quiz. Featured 
speakers were from the department, but also colleagues 
from the rest of South Africa, Uganda, Namibia, Malawi, as 
well as distinguished international guests and ex-South 
African, Prof Will Border, as well as Prof Nigel Wilson and 
Prof Craig Sable from New Zealand and United States of 
America, respectively. 
thiNK-tANK
Alongside the echo workshops, and in preparation for a 
major grant application, we ran an RHD research think-tank 
which featured luminaries in the RHD world such as Prof 
Carapetis and Dr Ana-Olga Mocumbi. 
ListeN to mY heArt
To round off the week’s activities, a patient and family event 
was held on Saturday 16 March. Over 50 heart patient 
families were hosted at the Red Cross War Memorial 
Children’s Hospital where children were treated to a soft 
play area, face painting and a magic show while their parents 
and care-givers watched a number of educational presen-
tations. Various topics including living with CHD, nutrition, 
sports and pregnancy were covered, after which everyone 
enjoyed a nutritious lunch. 
coNcLusioN
The event was a resounding success with 130 delegates 
from 19 countries and all 6 continents, making it truly global 
and giving attendees the opportunity to meet and network 
with experts in the fields of rheumatic and congenital 
heart disease. 
the iNAuGurAL ProteA worKshoP continued                              




Funding was provided by the University of Manchester, the University of Cape Town and CHDRU. In addition, several 
attendees also funded other delegates. Most African Fellows were supported in full and South African Fellows were supported 
in part and only paid minimal registration fees. A special thanks to Prof Bernard Keavney, from the University of Manchester, 
for his assistance and support. The meeting was fully organised by the CHDRU:, special thanks to Ms Lorrein Muhwava and 
Ms Jessica Abrams.
liesl zühlke and lisa telford
“My warmest thanks for your welcome and invitation to this outstanding meeting. Congratulations! Inspiring!”
A delegate from the World Health Organisation 
“I am writing this email with great joy and satisfaction 
to thank you for all your support and attention that 
allowed me to participate in the Inaugural PROTEA 
Workshop, this opportunity has filled me with 
enthusiasm to give more strength to the work we are 
developing in RHD, CHD, Echo diagnostics and also 
Heart Failure.”
Delegate from mozambique 
“Thank you for this amazing day: now having CHD 
does not make me feel so alone.”
rXH patient 
Some of the delegates at the conference.




Prof Peter Zilla, Head of the University of Cape Town’s 
Chris Barnard Division of Cardiothoracic Surgery, has 
been awarded Austria’s highest national accolade, the 
Grand Decoration of Honour for Services to the Republic 
of Austria.
The Austrian-born Zilla was recognised for his ground-
breaking work in the development of innovative concepts 
for trans-catheter heart valve technologies. He received 
the award, granted by the Federal President of the Republic 
of Austria, at a ceremony at Groote Schuur Hospital last 
week attended by about 60 people, including UCT Vice-
Chancellor Professor Mamokgethi Phakeng.
Zilla became head of the Chris Barnard Division of 
Cardiothoracic Surgery in 2000. Under his leadership, the 
department expanded both its staff and operations 
following a steep decline in adult cardiac surgery cases in 
the second half of the 1990s. Over the past decade, the 
department has become a leading training institution for 
cardiothoracic surgeons from across Africa.
In 2008, Zilla also co-founded Strait Access Technologies 
(SAT), of which he remains CEO and Medical Director. As 
a UCT start-up company, its objective is to provide access 
to heart valve therapies for millions of patients in the 
developing world.
university of cape town material – reprinted with 
permission
uct heArt surGeoN AwArded AustriA’s hiGhest 
NAtioNAL AccoLAde
Beth engelbrecht, mrs Suzy zilla and Prof Peter zilla.
the medal.
the Austrian Ambassador Brieger and Prof zilla.
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the south AfricAN heArt AssociAtioN
reseArch schoLArshiP
This scholarship is available to full and associate members of the SA Hear t® Association living in South Africa. 
It is primarily intended to assist colleagues involved in much-needed research to enhance their research 
programmes.
requiremeNts
■  Applicants need to be fully paid up members/associate members in good standing for at least one year.
■  Applications must include:
	 ■	The applicant’s abbreviated CV
	 ■	A breakdown of the anticipated expenses
	 ■	Ethics approval
	 ■	Full details of the research
	 ■	The completed application form  - please request a fillable MS Word document from erika@sahear t.org
	 ■	Contact details of Head of Depar tment or supervisor/mentor
recommeNdAtioNs
■   Preference will be given to early and mid-career applicants (<5 years post-qualification as specialist and/or 
<5 years post-PhD qualification).
coNditioNs
■   Applicants may only submit 1 application every second year. Preference is given to those who have not had 
previous scholarships awarded.
■   Awards are granted for one specific research project. Should that specific project be cancelled or the full 
amount allocated not be utilised for any reason, then the funds must rever t to SA Hear t®.
APPLicAtioNs must Be emAiLed to:
erika@sahear t.org
the seLectioN PANeL wiLL reView APPLicAtioNs ANNuALLY ANd the cLosiNG 
dAte is 30 sePtemBer 2019.
One scholarship to a maximum amount of R65 000 will be awarded annually.
sA heart® commits to inclusive excellence by advancing equity and diversity.
we particularly encourage applications from members of historically under 




we have had a roaring start to 2019 with a lecture series kicking off in the first term! iscAP 
would like to thank you for supporting these lecture meetings and thus contributing to the 
excellence we believe every cath lab should maintain, as well as conveying knowledge to our 
fellow colleagues.
iscAP NAtioNAL Lecture series 2019 (suPPorted BY merit medicAL)
Interventional Society for Cath Lab Allied Professionals (ISCAP) is focussed on ongoing training for all Cath Lab Allieds, 
including nurses, radiographers and technologists. 
On 26 January 2019, 66 Allied Professionals attended our workshop in Cape Town supported by Merit Medical SA. 
The following topics where discussed:
   Distal radial access          Uterine fibroid embolisation          Prostatic artery embolisation 
CPD Accredited for 3 Standard CEUs through the University of Pretoria.
During this workshop, we had the privilege of hosting the well acclaimed international speaker, Dr Darren Klass.
The second workshop of this series was held on 16 February 2019 in Durban at Coastlands on the Ridge Hotel, with 
Dr Werner van Straaten as faculty. We had a great turnout of 52 Allied Professionals attending the meeting. 
On 2 March 2019, we hosted the third workshop of this series supported by Merit Medical at Midrand Protea Hotel for 
the Gauteng region. A massive number of 62 Allied Professionals attended this workshop! We had the privilege of listening to 
Dr Michelle da Silva.
A receNt eVeNt tOOk PlAce IN POrt elIzABetH, AND AN uPcOmINg eVeNt IN BlOemfONteIN: 
11 may 2019: eastern cape – Port Elizabeth Ibyani Guest House.
20 July 2019: free State – Bloemfontein Leopard & Lace Guest House.
During this lecture series the attendees received a teal-coloured ISCAP & SASCI branded theatre buff. 
ISCAP thank Merit Medical for their support and commitment to making this lecture series a tremendous success.
iNterVeNtioNAL societY for cAth LAB ALLied 
ProfessioNALs
Allied professionals at IScAP gatherings.
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iscAP NAtioNAL Lecture series 2019 (suPPorted BY BostoN scieNtific, riVerdeNe 
ANd siemeNs)
On 16 March 2019, ISCAP hosted the first of this work-shop series in Port Elizabeth with a record attendance of 39 Allied 
Professionals! This series covered the following topics:
 ■  Stuck between a rock and a hard place: Rotational Atherectomy Overview 
 ■  contrast indications:  more than basics: Dr Ranchod
 ■  ethics of Artificial Intelligence in healthcare: Sinal Govender
CPD Accredited for 2 Standard and 1 Ethics CEU through the University of Pretoria.
On 6 April 2019, ISCAP hosted the second workshop of the Boston Scientific, Riverdene and Siemens series at Leopard & 
Lace, Bloemfontein. Twenty-eight Allied Professionals attended this workshop. We had the privilege of listening to Dr Visagie, 
Dr Ranchod and Ms Govender.
Allied professionals at IScAP gatherings.




Please diarise the following dates to ensure you do not miss 
out on this workshop series:
20 July 2019:  Gauteng Midrand Protea Hotel
3 August 2019:   Western Cape Cape Town, Century 
City Conference Centre
During this lecture series the attendees received an ISCAP 
branded string bag with corporate gifts from the sponsor-
ing industry, as well as a blue ISCAP & SASCI branded 
theatre buff. 
Dr Ranchod and Ms Govender will be traveling to all the 
different regions – you do not want to miss this workshop 
as we have had exceptional feedback up until now.
Thank you to Boston Scientific, Riverdene and Siemens for 
their unrestricted grant which made this lecture series 
possible.
iscAP NAtioNAL Lecture series 2019 
(suPPorted BY terumo ANd Vertice 
medtech GrouP)
Please Save the Date for the following workshops, made 
possible by the educational grant of Terumo and Vertice 
Healthcare:
24 August 2019:  Port Elizabeth Ibyani Guest House 
7 September 2019:  Bloemfontein Leopard &  
Lace Guest House
We also thank Biotronik for their sponsorship towards a 
fourth ISCAP Lecture Series and are currently looking for 
other industry representatives to partner with them.
iscAP continued                              
IScAP branded string bag with corporate gifts from 
the sponsoring industry, including a theatre buff.
If you wish to receive more communication regarding the 
ISCAP Workshops offered in your region or other CPD 
events and sponsorships, feel free to contact Joh-Ann Nice 
(joh-ann.nice@medsoc.co.za) or your regional chairperson.
The SASCI and ISCAP Executive Committee request that 
industry partners who are planning an additional workshop, 
kindly inform the ISCAP Office (joh-ann.nice@medsoc.
co.za) to ensure that there are no clashes.
On behalf of ISCAP, I would like to thank all those who 





15th ANNuAL sAsci feLLows 
worKshoP 
We are happy to announce the dates of the 15th Annual 
SASCI Fellows Workshop 2019 from 17 - 18 August, to be 
hosted at Faircity Quatermain Hotel in Sandton, Gauteng. 
The meeting in 2019 will once again be offered as a stand-
alone meeting as the combined SA Heart® Congress and 
AfricaPCR Course 2019 (in early November) are too long 
to add a preceding event of 2 full days.
The programme design will retain the unique SASCI 
approach and focus will be 100% on the Fellows and their 
clinical needs with networking opportunity. The work- 
shop caters for first to final year Fellows as well as recently 
qualified cardiologists. Last year, this event was attended by 
80% of Cardiology Fellows in South Africa as well as 5 
Fellows from Sudan – 50 practitioners in total  – and we 
look forward to welcoming them back in 2019. 
We request all Fellows to add the dates to your calendar 
and already start saving interesting cases for possible pre-
sentation, as two Registration sponsorships to SA Heart®/
AfricaPCR 2019 will be awarded to the best presentations. 
george Nel
executive Officer, HefSSA and SAScI
The SASCI 2019 academic calendar for experienced 
cardiologists had an exciting start with the South African 
rendition of the international Master the Complex series 
on 25 and 26 January, hosted in Bryanston at Boston 
Educare Training Facility. 
The programme was developed by SASCI Exco, Dr Dave 
Kettles and Prof Farrel Hellig, and Dr Awad Mohamed 
(Sudan), Chairperson of the PASCAR Interventional 
Cardiology Task Force, and saw almost 60 interventional 
cardiologists attend from South Africa, Kenya, Sudan, 
Mauritius and Namibia. 
The programme covered various aspects of complex inter-
ventional cardiology including live cases from The Royal 
Victoria Hospital, Belfast, Ireland, and Sunninghill Hospital, 
Johannesburg. This educational initiative was a great suc-
cess with well-renowned international faculty, Dr Simon 
Walsh and Dr Julian Strange, adding a lot of value. 
The case-based and practical approach of the meeting 
ensured learning opportunities for all the delegates. The 
delegates also gained exposure to the latest trends and 
technologies in interventional cardiology. SASCI is privi-
leged to be actively involved in this meeting and is working 
with PASCAR and Boston Scientific towards advancing 
cardiology education and training in South Africa and sub-
Saharan Africa. 
SAScI and Boston Scientific master the complex 2019 delegates.




heALth mArKet iNquirY (hmi)
EKA has summaries of the last submissions of stakeholders 
to the HMI, as well as the last workshops on market 
concentration and supplier-induced demand. Submissions 
closed on 26 April 2019. 
frAud, wAste ANd ABuse (fwA)
The FWA Summit (report available from EKA) concluded 
with certain stakeholders signing a Charter to that effect. 
Prominent stakeholders, such as the SA Medical Associa-
tion and most other provider groups, did not sign the 
Charter. Absent from the event, and the speakers or panels, 
were the larger private hospital groups and patient/
members of schemes. It is widely expected that an expan-
sion of FWA initiatives, in particular those targeting all 
types of healthcare professionals and smaller, independent 
facilities, will be expanded. Various presenters held the 
view that administrators should be able to share informa-
tion on FWA, which explains why a forensic investigation by 
one of the 3 largest administrators is followed by investi-
gations by the others. This could have a devastating effect 
on a practice, in particular in instances where the investi-
gation is about coding issues (and not fraud or theft). 
PeNALtY co-PAYmeNts
The CMS has declined to implement the ruling of the Final 
Appeal Board of the CMS to declare punitive or penalty 
co-pays an undesirable business practice for medical 
schemes. It has been supported in this decision by the 
Minister of Health. The argument is that the amendments 
to the Medical Schemes Act will remove the necessity to 
levy co-payments. We do not believe that that would be 
the case, when reviewing the amendments as proposed. 
Even if that is the case, such amendments are unlikely to be 
in effect within the next 18 months.
NAtioNAL heALth iNsurANce (Nhi)
The NHI project now appears, according to media reports, 
to reside within the Presidency. The last version of the NHI 
Bill was not approved by cabinet, and a new version is 
awaited. This version may be introduced into Parliament 
after the elections. 
sectioNs 18A ANd 18B exemPtioNs
The exemptions from section 18A and 18B of the Medicines 
Act, which should be published in the Government Gazette 
The following matters occurred in the first 4 months of 
2019 and merit consideration by all practitioners.
PmB reView
The Prescribed Minimum Benefits (PMB) Review timelines 
were released in broad terms. The Council for Medical 
Schemes (CMS) aims to complete the Primary Healthcare 
package within the next month or 2, after which it will be 
circulated for comment. 
For the rest of PMBs, the CMS will review those in view of 
publishing new regulations in 2020. This is an opportunity to 
look at how and where the current PMB algorithms and 
descriptions are outdated (e.g. need to make space for new 
technology, newer approaches to treating various heart 
conditions, etc.).
cms APPeAL committee cAses
The CMS as a Council sets up individuals from amongst 
themselves to fulfil the obligations of Appeals Committees 
in terms of sections 48 and 49 of the Medical Schemes Act, 
1998. Three important rulings were made in March 2019, 
and although none were in cardiology, the rulings are illus-
trative of the approaches taken by 3 different Committees, 
in which similar defences were raised by medical schemes 
against the non-payment of benefits.
the cases were on: 
 ■  treatment failure and the need to access next line 
therapy without having to co-pay;
 ■  where not treating with an alternative could cause the 
patient harm;
 ■  where the only appropriate alternative for a specific 
clinical situation is a non-protocol device.
In all 3 cases the scheme argued “state level of care”, which 
arguments were rejected in all 3. It was confirmed that even 
a state protocol is a still a protocol and must comply with 
the requirements of regulation 15H, namely be based on 
evidence-based medicine, and where treatment fails, or 
where the state protocol causes harm, or would cause 
harm, exceptions must still be made and funded in full. 
Redacted versions of the rulings are available on request, as 
well as CPD talks on the implications of the rulings, the 
PMBs and managed care.
sAsci ANd sA heArt® LeGAL uPdAte 
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to be lawful (in terms of section 36(1)), have not yet been 
published. This is in spite of the South African Health 
Products Regulatory Authority (SAHPRA) distributing the 
signed, but unpublished exemption as proof of its lawful-
ness. Strictly speaking, all deals that could fall within the 
ambit of these sections (bonuses, rebates, incentive schemes 
and samples/free supply) are currently unlawful. 
LiViNG wiLLs ANd dNrs
An amendment to the NHA has been proposed in 
Parliament on living wills and advanced directives. It also 
includes template documents, which would, if used, be 
lawful and enforceable. A copy of the proposed amend-
ment can be provided on request. It is recommended that 
stakeholders comment on the draft.
dePArtmeNt of LABour 
iNsPectioNs
Private practices have faced inspections by the Department 
of Labour over the past months. Inspectors now undertake 
a complete check of all labour law aspects in healthcare 
practices, and no longer limit their inspections to certain 
themes, e.g. Unemployment Insurance Fund, basic condi-
tions of employment or occupational health and safety. 
Ensuring a practice complies with payroll taxes (PAYE, UIF), 
labour law contract and benefits compliance, is registered 
at the Compensation Fund (and has a certificate to that 
effect), and is compliant with occupational health and safety, 
is imperative. 
The EKA team remains available to assist with any health 
law or policy-related matter :
elsabe klinck  Director
elsabe@elsabeklinckassociates.co.za
Patricia matseke  Director
pat@elsabeklinckassociates.co.za
yvonne Naidoo  Consultant
yvonne@elsabeklinckassociates.co.za
marieta meyer  Associate, Free State
eka_consultant2@elsabeklinckassociates.co.za
Pieter theron  Associate, Western Cape
eka_consultant3@elsabeklinckassociates.co.za




We kindly remind you that you can gain online access to the 
10th Annual conference of New Horizons in Echocardiography
https://www.livemedia.com/newhorizons18
If you are unable to attend the 10th Annual Congress in person, 








 sYmPosium iN durBAN feBruArY 2019
left to right:  Dr Abdulaziz Al khaldi (Head of 
Paediatric cardiac Surgery, Prince Sultan cardiac 
centre, riyadh), Professor charles yankah (cardiac 
surgeon, Berlin Heart Institute) and Dr Vinesh 
moodley (Paediatrician, lenmed ethekwini Hospital 
and Heart centre).  
lenmed ethekwini Hospital and Heart centre.
hiGhLiGhtiNG AdVANced techNiques iN comPLex 
coNGeNitAL heArt diseAse
The meeting comprised 3 sessions, with the first session 
entitled “Building a pulmonary artery reconstruction 
programme”, specifically highlighting the embryology, 
pathology and management of pulmonary atresia with 
ventricular septal defect and aorto-pulmonary collaterals. 
Dr Frank Hanley at the University of Stanford pioneered 
techniques of unifocalisation for this complex lesion, and 
Stanford alumnus Dr Al Khaldi shared his expertise with 
this technique and the Riyadh experience in establishing a 
successful unifocalisation programme. Dr Al Khaldi’s ele-
gant presentation was complemented by Prof Kinsley’s 
experience in rehabilitating pulmonary arteries in Africa 
during his 50-year career. Complex cases were then pre-
sented to the audience, followed by robust discussion and 
debate.  
The second session focussed on “Right ventricle to 
pulmonary artery conduits” and Dr Al Khaldi presented 
advanced techniques of establishing right ventricle to 
pulmonary artery continuity, with focus on the use of the 
bovine jugular valved conduit. Prof Kinsley presented an 
alternate view, favouring the use of non-valved conduits 
and creation of a monocusp valve. The increasing role of 
percutaneous implanted pulmonary valves was highlighted 
by Prof Brown, and 2 complex cases of infective endocar-
ditis of percutaneous pulmonary valves were presented 
and discussed by Dr Vosloo and Dr Reddy. 
The final session of the meeting centred on “Treating Atrial 
Fibrillation”, with a broad overview of the subject provided 
by Dr Mugabi and Prof Ntusi. The role of the interven-
sYmPosium iN durBAN feBruArY 2019 
The Congenital Heart Centre at Lenmed Ethekwini 
Hospital and Heart Centre in Durban recently hosted a 
meeting focussed on advanced techniques in congenital 
heart surgery. The meeting was built around the expertise 
of international guest speaker Dr Abdulaziz Al Khaldi, the 
Head of Paediatric Cardiac Surgery at the Prince Sultan 
Cardiac Centre in Riyadh, Saudi Arabia. Dr Al Khaldi’s special 
interests include complex pulmonary artery reconstruction 
techniques as well as antiarrhythmic surgery. 
Invited guest speakers included Prof Stephen Brown 
(paediatric cardiologist, University of the Free State), Prof 
Ntobeko Ntusi (Head of Medicine, University of Cape 
Town), Dr Susan Vosloo (paediatric cardiac surgeon, 
Christiaan Barnard Memorial Hospital, Cape Town), 
Dr Brian Vezi (electrophysiology cardiologist, Gateway 
Private Hospital, Durban), Dr James Fulton (cardiac surgeon, 
Mediclinic, Pietermaritzburg) and Dr Aine Mugabi (cardi-
ologist, Mediclinic, Pietermaritzburg). Lenmed Ethekwini 
Hospital congenital heart surgeons Prof Robin Kinsley and 
Dr Darshan Reddy chaired the meeting, which was well 
attended with an audience of over 70 participants, including 
adult and paediatric cardiologists, cardiac surgeons, physi-
cians and clinical technologists. 
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tional electrophysiology cardiologist was presented by Dr Vezi, who stressed the importance of patient risk stratification and 
appropriate pharmacological and catheter-based therapy to achieve rhythm control. Dr Al Khaldi demonstrated surgical options 
for atrial fibrillation, and specifically, the technical aspects of the Cox-Maze procedure. Dr Fulton summarised the key points of 
the session and facilitated the discussion.  
This meeting highlighted the advances in surgical and catheter-based therapy for right ventricular and pulmonary artery 
pathology from the neonate to adult, while addressing the atrial tachyarrhythmias that accompany these lesions. Dr Al Khaldi’s 
demeanour and dynamic presentation style kept the audience engaged and encouraged interaction during the course of the 
day. The Congenital Heart Centre at Lenmed Ethekwini Hospital looks forward to hosting future focus meetings and building 
relations with international experts in the field of congenital heart disease.   
Darshan reddy
Head: congenital Heart centre
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FMC. That includes, apart from correct initial management, 
also correct and speedy transfer to the nearest cath lab 
hospital. 
whAt is the curreNt stAtus of 
the Project? 
educAtioN 
STEMI SA with the assistance of Carica Combrink, Project 
Manager for the Angels initiative, and the support structure 
of Boehringer Ingelheim, developed training material that 
now also includes acute coronary syndrome and electro-
cardiogram (ECG) training. The latter was requested by our 
primary target audience. STEMI SA support this training 
initiative and will work with emergency physicians, emer- 
gency services and administrators towards achieving our 
goals. This new educational project will be known as the 
“Guardian Initiative”. 
The educational training material has been revised after the 
initial meeting following inputs received from all partici-
pants. It is divided into sub-categories to cater for training 
in the comprehensive and holistic ACS treatment sphere, 
including Emergency Medical Services, Emergency rooms, 
General Practitioners, Percutaneous Coronary Interven-
tion (PCI) information, etc. The latest AHA/ESC guidelines 
have been included. The material is in its final stages of 
referencing and the team are finalising a uniform protocol 
before sending it to the key players for comments and 
improvement. In the second part of 2019, we plan to 
arrange 2 - 4 monthly half-day training sessions. 
Dear Colleagues, STEMI SA Supporters, Industry, Emer-
gency Physicians and all others who are enthusiastic about 
improving Systems of Care of STEMI and ACS Management. 
StemI SA is expanding its horizons in 2019 to include 
Acute coronary Syndrome! 
I have been involved with finding solutions to improve 
STEMI care in South Africa since 2012. We have had many 
meetings, discussions, plans, strategies, etc. Many of these 
did not achieve all the goals we set, but we learned from 
all of them. I am convinced that the awareness, informa- 
tion and management of STEMI have improved. I have 
collaborated with Stent for Life (SFL); Stent Save a Life 
(SSL) STEMI India, STEMI Africa, SASCI, SA Heart®, 
AfricaPCR, EuroPCR, Angels (Stroke Systems of Care) and 
Heart and Stroke Foundation (HSF). Together with Prof 
Rhena Delport, our Project Manager, we contributed to 
articles and participated in several sessions. 
The project rests on these 3 pillars: 
 ■  Public awareness 
 ■  Clinical and healthcare provider (HCP) education 
 ■  Networking and data collection 
I am excited about the spin-offs of a STEMI System of 
Care Programme, namely: 
 ■  Benefits to all patients with Acute Coronary Syndrome 
(ACS).
 ■  Learning to network – work together in this fragmented 
healthcare environment.
 ■  Improving data collection habits, mentality as well as 
techniques. 
Central to this project’s success is the First Medical Contact 
(FMC) as this is the crucial point where things can go either 
well or badly/disappointingly. The cardiologists are well 
qualified and certainly essential, but without patients being 
managed correctly and efficiently at FMC the cardiologist 
can only repair some damage and be supportive. Despite 
the importance of the FMC it remains for the cath lab/hub 
hospitals to become involved in improving the care at 
New educational project.
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We are eager to hear of a Hub Hospital initiative 
where they are willing to embark on building their 
own effective referral networks. I am willing to assist 
where possible. 
Our starting meetings for 2019 are planned as follows and 
are dependent on funding we can secure for this purpose:
July 2019 NORTH WEST




OctOBer 2019 FREE STATE
Material is developed as per the below main categories 
which can be used in comprehensive ACS training and 
workshops. All the material will furthermore be available 
to all stakeholders involved with the initiative at no cost. 
Our main objective is education. 
Workshop Presentation: PArt 1 
Why focus on ACS? 
Workshop Presentation: PArt 2 
Epidemiology, risk factors, signs, symptoms, etc. 
Workshop Presentation: PArt 3A 
First Medical Contact 
Workshop Presentation: PArt 3B 
ECG Diagnostic Tool 
Workshop Presentation: PArt 3c 
ACS complications & management 
Workshop Presentation: PArt 4 
Pharmaceutical treatment options 
Workshop Presentation: PArt 5 
PCI at a glance 
Workshop Presentation: PArt 6 
STREAM trial 
Workshop Presentation: PArt 8 
STEMI networks 
As per our initial discussion in May 2018, we agreed that 
regional workshops aimed at FMC, Emergency departments 
without cath lab facilities, GPs and paramedics are essential 
in ensuring accurate treatment of all ACS patients within 
these channels and, furthermore, to ensure networks are 
established from all these areas in PCI-capable facilities for 
further treatment. We have developed a provisional agenda 
as well as proposed timeline for regional workshops to be 
implemented. Depending on funding available, we might be 
able to extend the regional workshops to additional regions. 
Naturally your input and guidance will be essential going 
forward. 





to all stakeholders 
involved with the 
initiative at no 





uPdAte oN stemi AfricA continued
participate in SSL Project managers discussion, learning 
from one another on how to collect data and improve our 
systems of care. 
I am still representing Africa as regional director of SSL 
now assisted by Dr Awad Mohamed of Sudan. (We plan a 
smaller meeting in Sudan later this year). 
dAtA coLLectioN
Rhena Delport is managing various ways to collect data. 
Our focus is working with a few centers, collecting data 
on the STEMI India Electronic platform. She also works 
with hospital groups such as Netcare, Mediclinic and Life 
Healthcare trying to persuade them to collect and share 
the same data. She works relentlessly and had numerous 
meetings with cardiologists and hospital groups. 
Data collection seems to be a slow, difficult process in an 
environment where we are not used to collecting data in 
private practice. In public health there is an issue of data 
ownership and subsequent fear. I believe we have lots of 
data on computers, unfortunately not analysed nor shared. 
We already have 440 cases to be analysed. Prof Delport 
will spend more focused time on this mission in the 
next year.
how Are we GoiNG to AchieVe 
our GoALs? 
carica combrink spends a lot of time assisting with the 
Guardian Initiative, focusing on education. 
chenita Vernon assisted us during 2018 with data collection. 
Dave kettels advises on SASCI Matters and assist with data 
collection role out. 
Jean Vorster assisted with the material for ECG training as 
well as the initial educational meetings in the UNITAS 
hospital’s referral area. 
cobus Badenhorst was also involved as speaker during 
the UNITAS referral area’s educational meetings. 
feroza motara and the WITS Emergency Physicians 
assisted with the first trail education meeting November 
AGeNdA for the meetiNGs
08:00 - 08:30  Registration and Breakfast 
08:30 - 09:35  ECG – Back to Basics 
09:35 - 10:20   ECG Workshop: Theory into 
Practice 
10:20 - 10:40  Tea Break 
10:40 - 11:10  FMC – Emergency Medical Services 
11:10 - 12:00  ACS Case Studies Workshop 
13:00 - 13:30   Treating ACS with the end goal in 
mind – What happens at the Hub? 
13:30 - 13:40  Closing and MCQ Answering 
13:40 - 14:40  Lunch and Departure 
For Wilgers hospital’s referral area I plan another two 
meetings in rural areas in 2019.
Material and important steps to implement within the next 
quarter. 
 ■  ACS Algorithm development 
 ■  Involvement of industry as partners to the Guardian 
Initiative to ensure enough resources 
 ■  Workbooks to be utilised at all workshops to encourage 
interactive participation and a standardised imple-
mentation process. 
 ■  MCQ Questions 
NetworKiNG
Added to training I propose that the hub hospital’s 
cardiologists take the responsibility for arranging meetings 
and training opportunities in their referral centers. 
STEMI SA will participate in the SSL Forum Meeting at 
EuroPCR as well as STEMI India meeting at the end of 
May 2019.
Our Project Manager Rhena Delport is working with SSL 
to produce a Bluebook Guidance for members of SSL like 
South Africa, working to improve systems of care for STEMI 
Management and Acute Coronary Syndrome. She will 
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assurance that funds sponsored will be allocated towards 
the dedicated programme for which the funds were 
donated i.e., education, networking or data collection.
1.   Register as a supporter of this initiative for a nominal 
yearly fee of R15 000. The funds will go towards the 
administration (an independent accountant has been 
appointed), travelling and the development and improve-
ment of our educational course. 
2.   Support our Guardian Initiative educational drive by 
sponsoring a specific course, meeting or a mini 2 hours 
rural course for a specific pre determined amount, be-
tween R20 000 and R50 000. The courses will run as 
Guardian – Guard your heart – ACS Training course 
with no branding on any of the lecture material. The 
sponsoring company will be fully involved as sponsors 
at the meeting as per usual when hosting a CPD accred-
ited meeting. 
3.   Support representative(s) of STEMI SA to attend SSL 
at EuroPCR; STEMI India; Project Managers Meeting 
at EuroPCR and later in the year in Germany; SAHeart®/
PASCAR/AfricaPCR 2019 and other relevant meetings. 
4.   Support our Data Collection efforts with advice, assis-
tance and funding for software, hardware, travel, project 
managers’ expenses and assistants needed. 
We need your assistance with this national education drive! 
Dr Adriaan Snyders 
cardiologist Wilgers Hospital 
StemI SA , Stent Save a life Africa 
2018, and has furthermore been a key role player, as well 
as steering committee member in developing the newly 
established Guardian Initiative. 
len Steingo, as adviser kept me level headed and parti-
cipated in the initial lecture series. 
During November 2018, I initiated and revisited 3 main 
referral centers for 2-hour training and networking oppor-
tunities with logistic support from BI. 
Funding can give this programme significant impetus. When 
attending meetings and congresses we had to rely on per-
sonal funds or where possible apply for sponsor assistance. 
Prof Delport also made funds available from her university 
research funds for certain expenses incurred. 
All around the world it is recommended that a not for pro-
fit company must be established with its own bank account 
managed by independent, knowledgeable person(s) who 
may include the donor with regular, specific reporting on 
the way the money is spent. We established STEMI SA 
NPC (Non-Profit Organisation) to make it easier for our 
supporters to assist either with finances or with other 
means of logistical and administrative support. 
We envisage a 1 - 2 days ACS Meeting in 2020 to include 
discussions with national institutions such as Training Insti-
tutions and the Government to improve systems of care for 
ACS management. 
As a supporter of this great initiative you can assist us in 
several ways. You will in return receive a 2-monthly report 
on activities as well as a detailed financial report with the 
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miss an infarct when they present with symptoms 1 cannot 
explain! Any person experiencing similar symptoms should 
immediately seek medical assessment.
Management most often goes astray at the FMC. All 
patients with chest pains should immediately have an 
electrocardiogram (ECG) done. Clear ST elevation, parti-
cularly with a typical history, is all that is needed to make 
the diagnosis. No need to wait for blood results or chest 
X-rays. Apart from routine resuscitation therapy, a deci- 
sion as to how to reperfuse the blocked coronary artery 
must be taken. Any reperfusion beyond 120 minutes of 
artery blockage will save very little heart muscle from 
undergoing necrosis. The guidelines are clear.
the guidelines on this are clear:
 ■  If the symptoms started within less than 60 minutes 
and the patient can be at a cath lab for primary 
intervention, this strategy should be followed. Direct 
communication with the treating cardiologist and 
emergency healthcare workers would be needed. If 
the transfer time to the cath lab is more than 30 
minutes, alternative therapy is indicated.
 ■  If this is not possible or the pain persists for more than 
6 - 12 hours or comes and goes, thrombolysis needs 
to be administered if no contraindications are present. 
Administering thrombolysis requires knowing the indi-
cations and contraindications. Thrombolysis should be 
available, and confidence in administering exist at FMC. 
Assistance is only a phone call away, and you should 
know whom to phone.
STEMI SA can provide a wall poster guiding you through 
the algorithm and is finalising a 1-day training course that 
will be presented at centres participating in our drive. This 
initiative for speedy, appropriate systems to open a blocked 
coronary artery saves lives, leaving the victim with a much 
better prognosis to continue working and being part of 
the economy for years to come.
To make a difference, healthcare workers at FMC need 
to be competent in taking and interpreting an ECG. The 
STEMI SA training course will assist in doing just that. 
To treat STEMI efficiently, having thrombolytics available 
should not be an option but obligation. Adjunctive therapy 
includes aspirin 300mg, low-molecular-weight heparin 30 - 
40mg IV and 60 - 80mg subcutaneous, and clopidogrel 
STEMI (S-T Elevation Myocardial Infarction) is an important 
diagnosis, potentially fatal, not difficult to diagnose and be 
treated effectively, thus saving lives and improving morbid-
ity. Being the core of acute coronary syndrome (ACS) and 
coronary artery disease, it ranks number 1 under non-com-
municable diseases in South Africa. Despite the presence 
of HIV and other infections, this will soon be the case in 
the rest of Africa.
Until recently, we were not doing well in managing STEMI. 
In public health, 60% of patients do not receive appropriate 
therapy in time, and 30% of those who die of STEMI could 
have been saved if treated according to the international 
guidelines. Understanding the diagnosis and treatment of 
STEMI also assists in treating patients with ACS and those 
who present with chest pain.
We know how to diagnose and treat STEMI – why then are 
we failing, considering that many documents and guidelines 
are available and frequently discussed? Our STEMI manage-
ment systems fail to provide the necessary care. Vital to 
improving STEMI management is the first medical contact 
(FMC), where the diagnosis needs to be made immediately 
including timely medication and transfer to a central capable 
hospital. In STEMI management, the clinic doctor, profes-
sional nurse and healthcare workers, porters, administra-
tors and emergency services play a more important role 
than the specialist.
The South African Heart Association (SA Heart®) and 
South African Society of Cardiovascular intervention 
(SASCI) run a project called “STEMI SA – Time is Muscle”, 
working with the international project “Stent Save a Life”, 
to improve systems of care and particularly assist those at 
the FMC. Should there be a need for more information 
about educational opportunities or you wish to participate/
contribute to this programme, you are invited to locate 
the STEMI SA activities’ link and contact details on the 
www. SASCI.co.za website.
Typical chest pains are central to the diagnosis of STEMI. 
A central retrosternal, pressing, burning, discomfort 
spreading to the shoulder, neck, jaw and left arm associated 
with sweating, nausea and dizziness can hardly be anything 
else than myocardial infarction. A typical chest pains, how-
ever, do not exclude the presence of an infarct, particu- 
larly in high-risk patients and those who have already had an 
event. Certain females are unique, so be careful not to 
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soon as possible. Know where to find a cath lab and whom 
to contact.
whAt if thromBoLYsis wAs 
AdmiNistered?
After haemodynamically stabilising the patient, transfer him/
her to a cath lab hospital as soon as possible.
Thrombolysis is not the end of therapy. Follow-up angio-
graphy is necessary even if reperfusion occurred, as reper-
fusion may not be optimal with adequate free coronary 
flow (TIMI III). An assessment of the other arteries is 
important for future management. If angiography is not 
done within 24 hours of the event, only ischaemia-driven 
interventions would be of any benefit.
Post-coronary intervention management includes opti-
mised medication, good lifestyle counselling, physical activ-
ity and regular evaluation. Target LDL cholesterol needs 
treatment to a level <1.8mmol/L. Smoking is out, i.e., not 
negotiable! The early morning blood pressure reading, 
before medication, should be 130/80 in hypertensive cases. 
300mg. A beta-blocker like bisoprolol 5mg, if not contra-
indicated, is not as critical as thought previously but still 
recommended. Oxygen is only necessary when needed 
with low O2 saturation. Morphine is given only in the pre-
sence of severe pain and discomfort but beware of nausea. 
Observe restless patients with/without neurologic derange-
ment and those with a very weird-looking ECG. Do not 
turn your back as you may need to start resuscitation. 
Consider ventilation if the patient is very restless. Know-
ledge about the renal function is important. Nevertheless, 
blood tests should not delay treatment. When in a central 
hospital, statin will be given.
What if you do not have thrombolysis and cannot have 
your patient at a cath lab in less than 30 minutes? The 
patient will surely suffer damage to the heart muscle 
because effective management was not available. Be 
informed and confident to manage the STEMI and have the 
necessary medication at hand to avoid contributing to 
unnecessary morbidity. In such a case do what you can, 
i.e., administer the adjunctive medication and transfer to a 
centre capable of managing STEMI – preferably a cath lab as 
Continued on page 176
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s-t eLeVAtioN mYocArdiAL iNfArctioN continued
 ■   Healthcare professionals should be able to diagnose 
STEMI, based on clinical observations and supported 
by ECG findings.
 ■  Healthcare professionals should be familiar with the 
treatment options for STEMI and immediately com-
mence appropriate therapy, depending on the time of 
onset of pain and the PCI- capability of the hospital. 
Transfer of the patient to a PCI-capability hospital for 
rescue PCI should be considered.
 ■  Tenecteplase, actilyse or streptokinase should be avail-
able at all secondary healthcare facilities for primary 
thrombolysis.
 ■  Healthcare professionals should have access to a cardi-
ologist or other trained professionals to assist with 
decision- making and appropriate transfer.
 ■  All specialist facilities should contribute to the SA 
Heart®/SASCI STEMI Early Reperfusion Registry to 
monitor treatment and outcome of STEMI cases for 
the optimisation of STEMI care nationally.
Regular, moderate exercise is the key to a symptom- and 
event-free future.
With effective management, the patient can be home and 
return to everyday life within a short time. However, 
delaying treatment causes frequent complications, which 
include renal impairment, pneumonia, decreased functional 
status, depression and emotional strain, and unfortunately 
also creating medically unfit persons who become a burden 
to others.
to summArise the KeY ruLes
 ■  Educate patients to recognise STEMI symptoms and 
understand the urgency of immediate treatment.
 ■  Patients should preferably contact EMS (Emergency 
Medical Services) and/or go to the nearest Percuta-
neous Coronary Intervention (PCI)-capable hospital 
or emergency room.
 ■  Immediately perform an ECG on all patients presenting 
with chest pain unless a very clear alternative cause is 
obvious.
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a cardiovascular event, the LDL should be less than 
1.8mmol/L.
 ■  Get enough hours of sleep but rise early.
 ■  Take time to finish your meals, do not rush!
 ■  Recognise danger signs in time.
 ■  Any symptoms, even if benign but progressive or asso-
ciated with others or affecting your quality of life, are 
serious and should be reported to your doctor.
 ■  Any symptom that improves or does not worsen with 
activity is unlikely to be significant.
 ■  An occluded coronary artery should be opened within 
120 minutes or less to limit damage to the heart.
 ■  Do not delay seeking help if you wake up with a burning 
pressing discomfort in the chest, feeling as if someone 
A few heArt heALth tiPs from mY 
BAcK PocKet
 ■  Everyone needs to spend time to ensure that he/she 
obtains a good cardiovascular health prognosis.
 ■  Exercise at least 3 - 5 hours per week.
 ■  If smoking, you are wasting your time.
 ■  Spend time to monitor your blood pressure, glucose 
and cholesterol levels.
 ■  Early morning blood pressure readings should not be 
more than 135/85mmHg before taking medication.
 ■  LDL cholesterol above 4mmol/L carries a high risk. 
With cardiovascular risk factors like hypertension this 
should be less than 3mmol/L; having diabetes, this 
should be less than 3.5mmol/L. If you already have had 
components of delay in StemI and ideal time intervals for intervention poster.
Continued on page 178
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s-t eLeVAtioN mYocArdiAL iNfArctioN continued
 ■  The most important risk factor for vascular events is 
a family history of vascular disease before age 50 or 60 
years.
 ■  Smoking and hormone replacement medication carry 
a high risk for cerebral infarction, particularly in women.
 ■  Smoking 20 cigarettes/day costs as much as a week’s 
holiday in Seychelles.
 ■  Having a home blood-pressure monitor costs less than 
spending one night in hospital.
 ■  You are not paying your doctor for the minutes or 
hours spent with you, but for the years of training and 
experience.
 ■  The effect of years of bad lifestyle habits cannot be 
reversed within hours or days.
Dr Adriaan Snyders 
cardiologist Wilgers Hospital 
StemI SA , Stent Save a life Africa 
is sitting on your chest and associated with nausea, 
sweating, dizziness, weakness or discomfort in the arms, 
particularly without improving within minutes. Report 
and have an ECG done within 10 minutes.
 ■  Most overweight persons have insulin resistance (no 
testing is necessary), rather start losing weight and 
exercise regularly.
 ■  Everybody has heart arrhythmias at times, which is 
unlikely to be significant if this improves with activity, 
(only robots never have heart palpitations/ arrhythmias).
 ■  Tiredness is rarely of cardiac origin, but the inappro-
priate shortness of breath during activity should always 
be investigated.
 ■  Do not ignore early morning headaches not associated 
with the previous night’s activities as these may indicate 
uncontrolled hypertension.
SA Heart®/SAScI early reperfusion project poster.
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trAVeL schoLArshiPs of the 
south AfricAN heArt AssociAtioN
Applications for the SA Hear t® Travel Scholarship for the third term in 2019 are invited to reach the SA Hear t® 
Office by 30 September 2019.
The scholarship is for the value of up to R25 000.00 for international meetings and R10 000.00 for local meetings.
This scholarship is available to all members and associate members residing in South Africa. It is primarily intended 
to assist junior colleagues to ensure continued par ticipation in local or international scientific meetings or 
workshops.
requiremeNts
■ Applicants must be fully paid-up members/associate members for at least 1 year.
recommeNdAtioNs
■  Early and mid-career applicants (<5 years post-qualification as specialist and/or <5 years post-PhD qualification).
■  Acceptance of an abstract/poster presentation at the scientific meeting to be attended.
coNditioNs
■  Awards will not be made for conferences or workshops retrospective to the application submission deadline. 
If the conference is taking place within six (6) weeks following the submission deadline, please indicate this in 
the appropriate place on the application form.
■  It is not a requirement for the abstract to be accepted by the conference travel application closing date. 
Should the acceptance of the paper, including proof of registration not be available at the time of submission 
of the application, then a provisional award may be made pending receipt of the acceptance of the paper.
■  Please ensure that applications are made as well in advance as possible (preferably at least 6 months prior 
to the conference date).
■  Applicants may only submit 1 application every second year. The scholarship is for the value of up to 
R25 000.00 for international meetings and R10 000.00 for local meetings.
■  Awards are only made in the event that a paper or a poster is being presented or in the event of a workshop 
attendance, if the reviewers deem the workshop attendance to be of high impact and consequently of benefit 
to the SA Hear t® community.
■  The applicant must ensure that the application is fully completed including the requirements as detailed in the 
checklist section. Applicants are asked to be concise and to only include applicable and relevant information.
■  Awards are granted for 1 specific conference. Should that specific conference be cancelled or the full amount 
allocated not utilised for any reason, then the funds must rever t to SA Hear t®; and
■  A written repor t on the relevant congress attended will need to be submitted by the successful applicant 
within 6 weeks of attending the congress. The congress repor t will be published in the South African Hear t 
Association Newsletter.
suBmissioN requiremeNts
■   Completed applications may be emailed to george@medsoc.co.za on or before the deadline date.  
■    Please request a fillable MS Word version of the application form from george@medsoc.co.za
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accepted by the relevant congress organising committee, 
the applicant will forfeit his or her sponsorship towards 
the congress. (Application can however be made well in 
advance of the relevant congress but will only be awarded 
on acceptance of the abstract.) A written report on the 
relevant congress attended will need to be submitted by 
the successful applicant within 6 weeks of attending the 
congress. The congress report will be published in the 
South African Heart Association Newsletter.
Applications should be sent to Dr Alfonso Pecoraro, 
President of the Western Cape branch of the South 
African Heart Association, Division of Cardiology, Tyger-
berg Hospital, Francie van Zijl Drive, Tygerberg 7505; or 
alternatively email: pecoraro@sun.ac.za.
Previous recipients of this prestigious award include 
Sandrine Lecour, Roisin Kelle, Liesl Zühlke and Prof Hans 
Strijdom.  
Applications close on 31 january 2020.
Louis VoGeLPoeL trAVeLLiNG schoLArshiP
A gifted and 
enthusiastic 
teacher, he was 
instrumental in  
the training of 
generations of 
undergraduates.
Applications are invited for the annual Louis Vogelpoel Travelling Scholarship for 2020. An amount of up to R20 000 towards the 
travel and accommodation costs of a local or interna- 
tional congress will be offered annually by the Western 
Cape branch of the South African Heart Association in 
memory of one of South Africa’s outstanding cardiologists, 
Dr Louis Vogelpoel. 
Louis Vogelpoel was a pioneer of cardiology in South 
Africa who died in April 2005. He was one of the 
founding members of the Cardiac Clinic at Groote Schuur 
Hospital and the University of Cape Town. He had an 
exceptional career of more than 5 decades as a dis-
tinguished general physician, cardiologist and horticultural 
scientist. Dr Vogelpoel’s commitment to patient-care, 
teaching and personal education is remembered by his 
many students, colleagues and patients. Medical students, 
house officers, registrars and consultants benefited from 
exposure to his unique blend of clinical expertise, extensive 
knowledge, enthusiasm and gracious style. 
A gifted and enthusiastic teacher, he was instrumental in 
the training of generations of undergraduates by regular 
bedside tutorials. He served as an outstanding role model 
for postgraduates and many who have achieved pro-
minence nationally and internationally acknowledged his 
contribution to the development of their careers. 
All applications for the scholarship will be reviewed by the 
executive committee of the Western Cape branch of the 
South African Heart Association. Preference will be given 
to practitioners or researchers in the field of cardiovascular 
medicine who are members of the South African Heart 
Association and are resident in the Western Cape.
Applications should include: (1) A brief synopsis of the 
work the applicant wishes to present at the congress; and 
(2) A brief letter of what the applicant hopes to gain by 
attending the relevant congress. The applicant should sub-
mit an abstract for presentation at the relevant national or 
international meeting. Should such an abstract not be 
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hefssA trAVeL schoLArshiP 
iNtroductioN
The Executive Committee of the Heart Failure Society of South Africa (HeFSSA) has established 
the HeFSSA Travel Scholarship. As part of its contribution towards optimising patient care and 
to enhance and promote local heart failure expertise, HeFSSA supports such an award in 
South Africa. We hope that the information gained during this event and the possibility of 
sharing your experience and opening a dialogue with other specialists, will broaden your 
knowledge regarding new products and therapies in your field of expertise. We also hope that 
this experience will help you to develop educational programmes at your medical institution 
and to share the acquired knowledge with your colleagues actively.
VALue
Two travel grants are available annually. Each grant is valued at a maximum of R35 000 which 
may be used towards economy airfare, registration and accommodation. 
eLiGiBiLitY
Candidates may be a medical practitioner in the public or private sector (i.e. a cardiologist, 
physician, internal medicine practitioner, Cardiology Fellow or similar) or researcher (basic 
scientist in heart failure). Applicants must be paid-up members of the SA Heart® Association 
and HeFSSA. The programme/course/conference needs to be internationally or locally 
accredited and focussed on promoting your knowledge of heart failure.
APPLicAtioN
Applications can be submitted to HeFSSA at info@hefssa.org. Please include your contact 
details and hospital affiliation, qualification, private and or public practice, and if you are an 
RSA citizen (or permanent resident). Provide a motivation as to why the specific programme 
or course has been selected and include the programme of the conference (or URL). The 
HeFSSA office will confirm receipt by return email. Application for this award does not 
guarantee that the applicant will receive the award. No correspondence will be entertained 
after a decision is made. The applicant will be notified of the outcome of the applications 
within 4 weeks of receipt.
Process ANd terms
The grant recipient needs to book, pay and then claim back (with proof documentation) from 
HeFSSA. Refund will be actioned within 24 hours. Twenty percent of the grant amount will be 
retained by HeFSSA (R7 000) and will be paid to the recipient as soon as CPD certificate and 
a meeting report is received.
Within one month of returning from the conference, the recipient must submit a substantial 
evaluation/review of the course content. This should reflect on key lectures and late-breaking 
trials as well as other sessions attended, which will impact on the practice going forward. Include 
some photographs. The purpose of this report is to share knowledge gained that could impact 
on colleagues’ practices. The report should be included in the SA Heart® newsletter and/or the 
HeFSSA newsletter. 
HefSSA strongly recommends that the recipient create the opportunity to give feedback 
through a lecture delivered at appropriate educational forums (please confirm with HefSSA 
when these take place).
Should the recipient not attend the conference, HefSSA reserves the right to request repay-
ment of any monies paid.
“eNhANciNG heArt fAiLure mANAGemeNt iN south AfricA”
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